Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DACH1 encodes a chromatin-associated protein that associates with other DNA-binding transcription factors to regulate gene expression and cell fate determination during development. Additionally we are shipping DACH1 Proteins (3) and DACH1 Kits (2) and many more products for this protein.
Showing 10 out of 73 products:
Human Polyclonal DACH1 Primary Antibody for WB - ABIN2778443
Wu, Katiyar, Li, Liu, Ju, Popov, Jiao, Lisanti, Casola, Pestell: Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. in Proceedings of the National Academy of Sciences of the United States of America 2008
Human Polyclonal DACH1 Primary Antibody for EIA, WB - ABIN375187
Wu, Yang, Wang, Davoli, DAmico, Li, Cveklova, Kozmik, Lisanti, Russell, Cvekl, Pestell: DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. in The Journal of biological chemistry 2003
The results of this study suggested the involvement of the mouse Dach1 gene in adult neurogenesis; cells expressing this gene exhibit the properties of adult NSCs or neuroblasts and respond to MCAo by enhanced neurogenesis.
find that in cells growin (show IGF1 Antibodies)g in IGF-1 (and unrespons (show EGF Antibodies)ive to EGF), DACH1 is devoid of tumor suppressor activity
The mouse dachshund gene is related to the Ski (show SKI Antibodies) proto-oncogene (show RAB1A Antibodies) and is expressed in eye and limb.
In the mouse, Dach1 expression in the developing ear also overlaps with the expression of Eya1 (show EYA1 Antibodies) (an eya homologue)
Dach1 is a target gene of FGF signaling during limb skeletal development, and Dach1 may function as an intermediary in the FGF signaling pathway regulating cell proliferation or differentiation
Dach1 is critical for postnatal survival of mice
The phosphatase function of Eya switches the function of Six1 (show SIX1 Antibodies)-Dach from repression to activation, causing transcriptional activation through recruitment of co-activators
The Pax (show PXN Antibodies)-Eya-Six-Dach network is at best only partly conserved during lens and nasal placode development.
DACH1 repressed cyclin D1 (show CCND1 Antibodies) through a novel mechanism via a c-Jun (show JUN Antibodies) DNA-binding partner, requiring the DACH1 alpha-helical DS domain which recruits corepressors to the local chromatin.
These studies demonstrate a novel mechanism by which DACH1 blocks c-Jun (show JUN Antibodies)-mediated contact-independent growth through repressing the c-Jun (show JUN Antibodies) delta domain.
Kaplan-Mier analysis of human NSCLC samples demonstrated that high DACH1 mRNA levels predicted favorable prognosis for relapse-free and overall survival. In agreement, high CXCL5 (show CXCL5 Antibodies) expression predicted a worse prognosis for survival.
DACH1 expression was reduced in hepatocellular carcinoma even at early stage and associated with tumor progression. Overexpression inhibited HCC (show FAM126A Antibodies) cell growth and migration by inactivating the Wnt (show WNT2 Antibodies) pathway via GSK3beta (show GSK3b Antibodies) phosphorylation to suppress beta-catenin (show CTNNB1 Antibodies).
In breast cancer, some GATA3 (show GATA3 Antibodies) effects shift from tumor suppressing to tumor promoting during tumorigenesis, with deregulation of three genes, BCL2 (show BCL2 Antibodies), DACH1, THSD4, representing major GATA3 (show GATA3 Antibodies)-controlled processes in cancer progression.
Results indicated that DACH1 was a novel molecular marker of RCC (show XRCC1 Antibodies) and it attributed to the malignant behavior of renal cancer cells.
Data indicate that dachshund family transcription factor 1 (show HNF1A Antibodies) (DACH1) suppresses gastric cancer cell proliferation, invasion and metastasis by inhibiting transforming growth factor beta (TGF-beta) signalling pathways both in vitro and in vivo.
results suggest that DACH1 loss of function results in increased cell growth, motility and invasiveness through TGF-beta (show TGFB1 Antibodies)-mediated EMT (show ITK Antibodies), and DACH1 loss of function has important therapeutic implications for targeted therapies of CRC (show CALR Antibodies)
DACH1 is a determinant of benign and malignant prostate epithelium cellular growth, migration, and cytokine abundance in vivo.
Further evaluation of the methylation of DACH1, DKK1 (show DKK1 Antibodies), and WIF1 (show WIF1 Antibodies) in a clinical patient group confirmed the frequent methylation of WIF1 (show WIF1 Antibodies) and intermediate or low frequency of methylation of DACH1 or DKK1 (show DKK1 Antibodies), respectively.
DACH1 inhibits aldosterone secretion in human adrenals, and transforming growth factor-beta signaling pathway is activated in DACH1 overexpressed cells and may mediate inhibition of aldosterone secretion in human adrenals.
Familial young-onset diabetes, pre-diabetes and cardiovascular disease are associated with genetic variants of DACH1 in Chinese
This gene encodes a chromatin-associated protein that associates with other DNA-binding transcription factors to regulate gene expression and cell fate determination during development. The protein contains a Ski domain that is highly conserved from Drosophila to human. Expression of this gene is lost in some forms of metastatic cancer, and is correlated with poor prognosis. Multiple transcript variants encoding different isoforms have been found for this gene.
dachshund homolog 1 (Drosophila)
, dachshund homolog 1
, dachshund 1
, dachshund protein
, dachshund homolog 1-like